tirzepatide a glp1 GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 Compounded GLP-1 - Semaglutide &
Description
In addition to DRG, the spinal dorsal horn showed glutamatergic changes in chronic pain through enhanced excitatory neurotransmission, viz., glutamatergic signaling
Studies show an average weight loss of 15% over 68 weeks
The first and most common is a Wegovy plateau
It helps curb cravings, ease bloat, and naturally doubles GLP-1 levels
